Overview Safety Study of Lifitegrast to Treat Dry Eye Status: Completed Trial end date: 2014-03-03 Target enrollment: Participant gender: Summary The purpose of the study is to evaluate the safety of lifitegrast ophthalmic solution compared to placebo in the treatment of dry eye as assessed by ocular and non-ocular adverse events when administered BID for approximately 1 year. Phase: Phase 3 Details Lead Sponsor: ShireTreatments: LifitegrastOphthalmic Solutions